Atlas Trials

Phase I Single Ascending Dose and Multiple Ascending Doses of Oral AFA-281 in Healthy Volunteers

Clinical trial NCT05547503 · COMPLETED

Trial details

NCT number
NCT05547503
Sponsor
Afasci Inc
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pain, NeuropathicPain, Inflammatory
Start date
2023-04-11
Primary completion
2024-12-04
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.